{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:32:10Z","timestamp":1794357130556,"version":"4.9.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA274967"],"award-info":[{"award-number":["R01CA274967"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The human Y chromosome (ChrY), which confers male sex determination, contains a relatively small number of protein-coding genes compared to other chromosomes; consequently, its functional impact on adult physiology was once severely unappreciated. While the repetitive structure of the ChrY once impeded sequencing, technological advances have now made it possible to identify its contents. Despite the historical view of ChrY as a virtual wasteland, we now know that it encodes a variety of genes which are hugely consequential to both human health and disease. The extreme downregulation of ChrY gene expression, resulting from partial or total loss of ChrY (LOY), is a common characteristic observed in various disease states in men, including cardiovascular, neurodegenerative, immunological health issues, and ,most\u00a0notably, cancer. Additionally, mosaic LOY (mLOY) is sometimes found in primary cancerous tissues and is associated with poorer clinical outcome. Although, the reasons for these associations were once elusive, they are now understood to be linked to the activity of several ChrY genes, as well as the pleiotropic effects of their loss. In this review, we critically analyze contemporary and historic scientific literature which evaluate the clinical LOY trends seen in male exclusive\/predominant cancers as well as explore the now identified mechanisms of ChrY alteration in cancer initiation, progression, and metastasis. Moreover, we discuss recent research studies which have uncovered novel mechanisms through which LOY may induce the physiological and molecular changes in the tumor microenvironment (TME) associated with malignant transformation and the evasion of innate immunity. Interestingly, the TME formed by malignant cells with LOY appears to contribute to early T cell exhaustion in infiltrating immune cells and consequent compromised tumor clearance; a phenomenon which has been profusely observed in patient samples. Furthermore, we describe the tumor-suppressive activities of the ChrY demonstrated in previous studies, as well as its newly identified roles in cancer immunology.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s11658-025-00812-9","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:47:51Z","timestamp":1762775271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Y-chromosome alteration and its impact on cancer progression and metastasis"],"prefix":"10.1186","volume":"30","author":[{"given":"Sarah Ann","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merana","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathiksha","family":"Prabhakaraalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipra","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Kyprianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-2621","authenticated-orcid":false,"given":"Goutam","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"812_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.hdy.6800856","volume":"97","author":"OS Harman","year":"2006","unstructured":"Harman OS. The man who invented the chromosome. Heredity. 2006;97:136.","journal-title":"Heredity"},{"issue":"1\u20132","key":"812_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00439-005-0121-x","volume":"119","author":"PS Harper","year":"2006","unstructured":"Harper PS. The discovery of the human chromosome number in Lund, 1955\u20131956. Hum Genet. 2006;119(1\u20132):226\u201332.","journal-title":"Hum Genet"},{"issue":"377","key":"812_CR3","first-page":"20210215","volume":"2022","author":"SB Carey","year":"1850","unstructured":"Carey SB, Akozbek L, Harkess A. The contributions of Nettie Stevens to the field of sex chromosome biology. Philos Trans R Soc Lond B Biol Sci. 1850;2022(377):20210215.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"812_CR4","doi-asserted-by":"publisher","DOI":"10.5962\/bhl.title.56517","volume-title":"Studies in spermatogenesis; accessory chromosome","author":"N Stevens","year":"1905","unstructured":"Stevens N. Studies in spermatogenesis; accessory chromosome. Washington, DC: Carnegie Institution of Washington; 1905."},{"key":"812_CR5","volume-title":"Studies in spermatogenesis\u2014.II; A comparative study of the heterochromosomes in certain species of coleoptera, hemiptera, and lepidoptera, with especial reference to sex determination","author":"N Stevens","year":"1906","unstructured":"Stevens N. Studies in spermatogenesis\u2014.II; A comparative study of the heterochromosomes in certain species of coleoptera, hemiptera, and lepidoptera, with especial reference to sex determination. Washington, DC: Carnegie institution of Washington; 1906."},{"issue":"1500","key":"812_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1126\/science.58.1500.247","volume":"58","author":"TS Painter","year":"1923","unstructured":"Painter TS. Further observations on the sex chromosomes of mammals. Science. 1923;58(1500):247\u20138.","journal-title":"Science"},{"issue":"6300","key":"812_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/348448a0","volume":"348","author":"P Berta","year":"1990","unstructured":"Berta P, Hawkins JB, Sinclair AH, Taylor A, Griffiths BL, Goodfellow PN, et al. Genetic evidence equating SRY and the testis-determining factor. Nature. 1990;348(6300):448\u201350.","journal-title":"Nature"},{"key":"812_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrg1124","volume":"4","author":"MA Jobling","year":"2003","unstructured":"Jobling MA, Tyler-Smith C. The human Y chromosome: an evolutionary marker comes of age. Nat Rev Genet. 2003;4:598\u2013612.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"812_CR9","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1128\/MCB.18.11.6653","volume":"18","author":"PNBMBPGFP De Santa BarbaraBonneaudBoizetDescloze","year":"1998","unstructured":"De Santa BarbaraBonneaudBoizetDesclozeauxMoniotSudbeckSchererPoulatBerta PNBMBPGFP. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol. 1998;18(11):6653\u201365.","journal-title":"Mol Cell Biol"},{"key":"812_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna10020021","author":"ES Westemeier-Rice","year":"2024","unstructured":"Westemeier-Rice ES, Winters MT, Rawson TW, Martinez I. More than the SRY: the non-coding landscape of the Y chromosome and its importance in human disease. Noncoding RNA. 2024. https:\/\/doi.org\/10.3390\/ncrna10020021.","journal-title":"Noncoding RNA"},{"key":"812_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1242\/dev.101.Supplement.77","volume":"101","author":"KD Smith","year":"1987","unstructured":"Smith KD, Young KE, Talbot CC Jr, Schmeckpeper BJ. Repeated DNA of the human Y chromosome. Development. 1987;101:77\u201392.","journal-title":"Development"},{"issue":"7978","key":"812_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41586-023-06457-y","volume":"621","author":"A Rhie","year":"2023","unstructured":"Rhie A, Nurk S, Cechova M, Hoyt SJ, Taylor DJ, Altemose N, et al. The complete sequence of a human Y chromosome. Nature. 2023;621(7978):344\u201354.","journal-title":"Nature"},{"key":"812_CR13","unstructured":"Zhou Q. The \u201cselfish\u201d sex chromosome 2017. https:\/\/medienportal.univie.ac.at\/uniview\/forschung\/detailansicht\/artikel\/the-selfish-sex-chromosome\/."},{"issue":"1","key":"812_CR14","first-page":"18","volume":"1","author":"F LsQ-MaM","year":"2001","unstructured":"LsQ-MaM F. The human Y chromosome: the biological role of a \u201cfunctional wasteland.\u201d J Biomed Biotechnol. 2001;1(1):18\u201324.","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"812_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cell.2006.02.024","volume":"124","author":"JA Graves","year":"2006","unstructured":"Graves JA. Sex chromosome specialization and degeneration in mammals. Cell. 2006;124(5):901\u201314.","journal-title":"Cell"},{"issue":"4","key":"812_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cell.2014.09.052","volume":"159","author":"YS Soh","year":"2014","unstructured":"Soh YS, Alf\u00f6ldi J, Pyntikova T, Brown LG, Graves T, Minx PJ, et al. Sequencing the mouse Y chromosome reveals convergent gene acquisition and amplification on both sex chromosomes. Cell. 2014;159(4):800\u201313.","journal-title":"Cell"},{"issue":"9","key":"812_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jnci\/djz232","volume":"112","author":"A Caceres","year":"2020","unstructured":"Caceres A, Jene A, EskoPerez-JuradoGonzalez TLAJR. Extreme downregulation of chromosome Y and cancer risk in men. J Natl Cancer Inst. 2020;112(9):913\u201320.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"812_CR18","doi-asserted-by":"publisher","first-page":"e0146264","DOI":"10.1371\/journal.pone.0146264","volume":"11","author":"P Noveski","year":"2016","unstructured":"Noveski P, Madjunkova S, Sukarova Stefanovska E, Matevska Geshkovska N, Kuzmanovska M, Dimovski A, et al. Loss of Y chromosome in peripheral blood of colorectal and prostate cancer patients. PLoS ONE. 2016;11(1):e0146264.","journal-title":"PLoS ONE"},{"issue":"3","key":"812_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1534\/genetics.120.303324","volume":"215","author":"J Zhang","year":"2020","unstructured":"Zhang J, Luo J, Chen J, Dai J, Montell C. The role of Y chromosome genes in male fertility in drosophila melanogaster. Genetics. 2020;215(3):623\u201333.","journal-title":"Genetics"},{"issue":"12","key":"812_CR20","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1093\/molbev\/msx250","volume":"34","author":"AP Morgan","year":"2017","unstructured":"Morgan AP, de Pardo-Manuel Villena F. Sequence and structural diversity of mouse Y chromosomes. Mol Biol Evol. 2017;34(12):3186\u2013204.","journal-title":"Mol Biol Evol"},{"issue":"1","key":"812_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2013.03.001","volume":"753","author":"EA Carlson","year":"2013","unstructured":"Carlson EA. How fruit flies came to launch the chromosome theory of heredity. Mutat Res. 2013;753(1):1\u20136.","journal-title":"Mutat Res"},{"issue":"10","key":"812_CR22","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/molbev\/msaa082","volume":"37","author":"EJ Brown","year":"2020","unstructured":"Brown EJ, Nguyen AH, Bachtrog D. The drosophila Y chromosome affects heterochromatin integrity genome-wide. Mol biol and evol. 2020;37(10):2808\u201324.","journal-title":"Mol biol and evol."},{"issue":"2","key":"812_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1101\/gr.217602","volume":"12","author":"Consortium YC","year":"2002","unstructured":"Consortium YC. A nomenclature system for the tree of human Y-chromosomal binary haplogroups. Genome Res. 2002;12(2):339\u201348.","journal-title":"Genome Res"},{"issue":"3","key":"812_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/00087114.2015.1032614","volume":"63","author":"HE Ero\u011flu","year":"2015","unstructured":"Ero\u011flu HE. Which chromosomes are subtelocentric or acrocentric? A new karyotype symmetry\/asymmetry index. Caryologia. 2015;63(3):239\u201345.","journal-title":"Caryologia"},{"key":"812_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-023-06425-6","volume":"621","author":"P Hallast","year":"2023","unstructured":"Hallast P, Ebert P, Loftus M, Yilmaz F, Audano PA, Logsdon GA, et al. Assembly of 43 diverse human Y chromosomes reveals extensive complexity and variation. Nature. 2023;621:355\u201364.","journal-title":"Nature"},{"issue":"2","key":"812_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/138920207780368141","volume":"8","author":"A Helena Mangs","year":"2007","unstructured":"Helena Mangs A, Morris BJ. The human pseudoautosomal region (PAR): origin, function and future. Curr Genom. 2007;8(2):129\u201336.","journal-title":"Curr Genom"},{"issue":"6942","key":"812_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nature01722","volume":"423","author":"H Skaletsky","year":"2003","unstructured":"Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003;423(6942):825\u201337.","journal-title":"Nature"},{"issue":"11","key":"812_CR28","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1101\/gr.203001","volume":"11","author":"J Perry","year":"2001","unstructured":"Perry J, Palmer S, Gabriel A, Ashworth A. A short pseudoautosomal region in laboratory mice. Genome res. 2001;11(11):1826\u201332.","journal-title":"Genome res"},{"issue":"1","key":"812_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/1471-2164-9-468","volume":"9","author":"MA Levy","year":"2008","unstructured":"Levy MA, Fernandes AD, Tremblay DC, Seah C, B\u00e9rub\u00e9 NG. The SWI\/SNF protein ATRX co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome. BMC genom. 2008;9(1):468.","journal-title":"BMC genom"},{"issue":"1","key":"812_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12958-018-0330-5","volume":"16","author":"S Colaco","year":"2018","unstructured":"Colaco S, Modi D. Genetics of the human Y chromosome and its association with male infertility. Reprod Biol Endocrinol. 2018;16(1):14.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"812_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nrm.2015.5","volume":"17","author":"KL McKinley","year":"2016","unstructured":"McKinley KL, Cheeseman IM. The molecular basis for centromere identity and function. Nat Rev Mol Cell Biol. 2016;17(1):16\u201329.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"812_CR32","unstructured":"Information NCfB. PubMed: NIH; National Library of Medicine; Search results and meta data on scientific publications related to the term \u201c (Y chromosome[Title])\u201d. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=%28Y+chromosome%5BTitle%5D%29&filter=years.1972-1972&sort=pubdate&sort_order=asc."},{"issue":"9","key":"812_CR33","first-page":"14634","volume":"8","author":"XW Yu","year":"2015","unstructured":"Yu XW, Wei ZT, Jiang YT, Zhang SL. Y chromosome azoospermia factor region microdeletions and transmission characteristics in azoospermic and severe oligozoospermic patients. Int J Of Clin Exp Med. 2015;8(9):14634.","journal-title":"Int J Of Clin Exp Med."},{"key":"812_CR34","unstructured":"Information NCfB. PubMed: National Library of Medicine; 2025. Publications and publication metadata avalible on the PubMed database related to the search terms \u201c (Y chromosome) AND (case study)\u201d. https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=%28Y+chromosome%29+AND+%28case+study%29&sort=pubdate&sort_order=asc."},{"issue":"1","key":"812_CR35","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1038\/s41467-019-12705-5","volume":"10","author":"C Terao","year":"2019","unstructured":"Terao C, Momozawa Y, Ishigaki K, Kawakami E, Akiyama M, Loh PR, et al. GWAS of mosaic loss of chromosome Y highlights genetic effects on blood cell differentiation. Nat Commun. 2019;10(1):4719.","journal-title":"Nat Commun"},{"issue":"1","key":"812_CR36","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1038\/s41467-020-19653-5","volume":"11","author":"RJ Loos","year":"2020","unstructured":"Loos RJ. 15 years of genome-wide association studies and no signs of slowing down. Nat Commun. 2020;11(1):5900.","journal-title":"Nat Commun"},{"issue":"3","key":"812_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1158\/0008-5472.CAN-18-2566","volume":"79","author":"E Loftfield","year":"2019","unstructured":"Loftfield E, Zhou W, Yeager M, Chanock SJ, Freedman ND, Machiela MJ. Mosaic Y loss is moderately associated with solid tumor risk. Cancer Res. 2019;79(3):461\u20136.","journal-title":"Cancer Res"},{"issue":"1","key":"812_CR38","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1038\/s41598-018-30759-1","volume":"8","author":"E Loftfield","year":"2018","unstructured":"Loftfield E, Zhou W, Graubard BI, Yeager M, ChanockFreedman SJND, et al. Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank. Sci Rep. 2018;8(1):12316.","journal-title":"Sci Rep"},{"issue":"6217","key":"812_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/science.1262092","volume":"347","author":"JP Dumanski","year":"2015","unstructured":"Dumanski JP, Rasi C, Lonn M, Davies H, Ingelsson M, Giedraitis V, et al. Mutagenesis. Smoking is associated with mosaic loss of chromosome Y. Science. 2015;347(6217):81\u20133.","journal-title":"Science"},{"issue":"7497","key":"812_CR40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nature13206","volume":"508","author":"DWJFHLGTTJ BellottHughesSkaletskyBrownPyntikov","year":"2014","unstructured":"BellottHughesSkaletskyBrownPyntikovaCho DWJFHLGTTJ, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature. 2014;508(7497):494\u20139.","journal-title":"Nature"},{"issue":"6","key":"812_CR41","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.ajhg.2016.05.014","volume":"98","author":"JP Dumanski","year":"2016","unstructured":"Dumanski JP, Lambert JC, Rasi C, Giedraitis V, Davies H, Grenier-Boley B, et al. Mosaic loss of chromosome Y in blood is associated with Alzheimer disease. Am J Hum Genet. 2016;98(6):1208\u201319.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"812_CR42","doi-asserted-by":"publisher","first-page":"e115835","DOI":"10.1371\/journal.pone.0115835","volume":"9","author":"J Both","year":"2014","unstructured":"Both J, Krijgsman O, Bras J, Schaap GR, Baas F, Ylstra B, et al. Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma. PLoS ONE. 2014;9(12):e115835.","journal-title":"PLoS ONE"},{"issue":"7916","key":"812_CR43","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele CD, Abbasi A, Islam SA, Bowes AL, Khandekar A, Haase K, et al. Signatures of copy number alterations in human cancer. Nature. 2022;606(7916):984\u201391.","journal-title":"Nature"},{"issue":"6","key":"812_CR44","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s10522-024-10133-7","volume":"25","author":"F Abou Abdallah","year":"2024","unstructured":"Abou Abdallah F, Abdel Massih C, Attieh C, Chebly A. The impact of mosaic loss of the Y chromosome (mLOY) in men of advanced age. Biogerontology. 2024;25(6):943\u201355.","journal-title":"Biogerontology"},{"key":"812_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf072","author":"KW Soichi Sano","year":"2025","unstructured":"Soichi Sano KW. Loss of the Y chromosome in coronary artery disease. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf072.","journal-title":"Eur Heart J"},{"issue":"6603","key":"812_CR46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.abn3100","volume":"377","author":"S Sano","year":"2022","unstructured":"Sano S, Horitani K, Ogawa H, Halvardson J, Chavkin NW, Wang Y, et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science. 2022;377(6603):292\u20137.","journal-title":"Science"},{"issue":"1","key":"812_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13073-022-01144-5","volume":"14","author":"B Bruhn-Olszewska","year":"2022","unstructured":"Bruhn-Olszewska B, Sarkisyan DH, Juhas U, Rychlicka-Buniowska E, W\u00f3jcik M, Horbacz M, et al. Loss of Y in leukocytes as a risk factor for critical COVID-19 in men. Genom Med. 2022;14(1):139.","journal-title":"Genom Med"},{"key":"812_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111979","author":"DM Hozakowska-Roszkowska","year":"2024","unstructured":"Hozakowska-Roszkowska DM, Mengel-From J, Hristozova TK, Pedersen JK, Jeune B, Andersen-Ranberg K, et al. Mosaic loss of Y chromosome and the association to mortality in Danish men aged 56\u2013100 years. Mech Ageing Dev. 2024. https:\/\/doi.org\/10.1016\/j.mad.2024.111979.","journal-title":"Mech Ageing Dev"},{"issue":"12","key":"812_CR49","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/gcc.22282","volume":"54","author":"C Ganster","year":"2015","unstructured":"Ganster C, K\u00e4mpfe D, Jung K, Braulke F, Shirneshan K, Machherndl-Spandl S, et al. New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes. Genes, Chromosom and Cancer. 2015;54(12):717\u201324.","journal-title":"Genes, Chromosom and Cancer."},{"issue":"4","key":"812_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00439-020-02114-w","volume":"139","author":"X Guo","year":"2020","unstructured":"Guo X, Dai X, Zhou T, Wang H, Ni J, Xue J, et al. Mosaic loss of human Y chromosome: what, how and why. Human Genet. 2020;139(4):421\u201346.","journal-title":"Human Genet"},{"issue":"1","key":"812_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1189\/jlb.0811427","volume":"92","author":"SL Klein","year":"2012","unstructured":"Klein SL, Hodgson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J leukoc biol. 2012;92(1):67\u201373.","journal-title":"J leukoc biol"},{"issue":"13","key":"812_CR52","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1073\/pnas.1620889114","volume":"114","author":"DN Krementsov","year":"2017","unstructured":"Krementsov DN, Case LK, Dienz O, Raza A, Fang Q, Ather JL, et al. Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection. Proc Nati Aca Sci U S A. 2017;114(13):3491\u20136.","journal-title":"Proc Nati Aca Sci U S A."},{"issue":"1","key":"812_CR53","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s42003-024-05805-6","volume":"7","author":"LA P\u00e9rez-Jurado","year":"2024","unstructured":"P\u00e9rez-Jurado LA, C\u00e1ceres A, Balagu\u00e9-Dob\u00f3n L, Esko T, L\u00f3pez de Heredia M, Quintela I, et al. Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2. Commun Biol. 2024;7(1):202.","journal-title":"Commun Biol"},{"issue":"4","key":"812_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1","volume":"30","author":"RVHC PierreHoagland","year":"1972","unstructured":"PierreHoagland RVHC. Age-associated aneuploidy: loss of Y chromosome from human bone marrow cells with aging. Cancer. 1972;30(4):889\u201394.","journal-title":"Cancer"},{"issue":"3","key":"812_CR55","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s12325-023-02758-w","volume":"41","author":"AK Mankan","year":"2024","unstructured":"Mankan AK, Mankan N, de LasRamkissoonBodriagovaVidal HBSHOL, et al. Bladder cancer, loss of Y chromosome, and new opportunities for immunotherapy. Adv Ther. 2024;41(3):885\u201390.","journal-title":"Adv Ther"},{"issue":"11","key":"812_CR56","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","volume":"21","author":"JS Brown","year":"2023","unstructured":"Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Updating the Definition of Cancer. Mol Cancer Res. 2023;21(11):1142\u20137.","journal-title":"Mol Cancer Res"},{"key":"812_CR57","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.csbj.2023.02.024","volume":"21","author":"P Muller","year":"2023","unstructured":"Muller P, Velazquez Camacho O, Yazbeck AM, Wolwer C, Zhai W, Schumacher J, et al. Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome. Comput Struct Biotechnol J. 2023;21:1573\u201383.","journal-title":"Comput Struct Biotechnol J"},{"issue":"10","key":"812_CR58","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/ijc.27924","volume":"132","author":"PH Duijf","year":"2013","unstructured":"Duijf PH, Schultz N, Benezra R. Cancer cells preferentially lose small chromosomes. Int j cancer. 2013;132(10):2316\u201326.","journal-title":"Int j cancer"},{"issue":"3","key":"812_CR59","first-page":"268","volume":"28","author":"MT Dorak","year":"2012","unstructured":"Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front genet. 2012;28(3):268.","journal-title":"Front genet"},{"issue":"7497","key":"812_CR60","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nature13151","volume":"508","author":"D Cortez","year":"2014","unstructured":"Cortez D, Marin R, Toledo-Flores D, Froidevaux L, Liechti A, Waters PD, et al. Origins and functional evolution of Y chromosomes across mammals. Nature. 2014;508(7497):488\u201393.","journal-title":"Nature"},{"issue":"1","key":"812_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13578-021-00741-y","volume":"12","author":"R Heydari","year":"2022","unstructured":"Heydari R, Jangravi Z, Maleknia S, Seresht-Ahmadi M, Bahari Z, Salekdeh GH, et al. Y chromosome is moving out of sex determination shadow. Cell Biosci. 2022;12(1):4.","journal-title":"Cell Biosci"},{"issue":"9","key":"812_CR62","first-page":"433","volume":"125","author":"G Cardini","year":"1968","unstructured":"Cardini G, Clemente R, Bersi M. Peculiar chromosomal pattern in a case of acute myeloblastic leukaemia in a patient with XY\/XO mosaic. Arch Sci Med. 1968;125(9):433\u20138.","journal-title":"Arch Sci Med"},{"issue":"6","key":"812_CR63","first-page":"697","volume":"10","author":"F Bauters","year":"1970","unstructured":"Bauters F, Croquette MF, Delmas-Marsalet Y, Deminatti M, Goudemand M. A peculiar form of granulocytic leukemia in the male: prolonged development and the presence of the Philadelphia chromosome, with the loss of Y chromosome in the myeloid cells (apropos of 3 cases). Nouv rev fr d\u2019hematol. 1970;10(6):697\u2013707.","journal-title":"Nouv rev fr d'hematol."},{"issue":"7802","key":"812_CR64","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0140-6736(73)90363-2","volume":"301","author":"L Vass","year":"1973","unstructured":"Vass L, Sellyei M. The missing Y chromosome and human leukaemia. The Lancet. 1973;301(7802):550\u20131.","journal-title":"The Lancet"},{"issue":"9","key":"812_CR65","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3324\/haematol.2009.019109","volume":"95","author":"E Lippert","year":"2010","unstructured":"Lippert E, Mozziconacci MJ, Laibe S, Gervais C, Girault S, Gachard N, et al. Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica. 2010;95(9):1604\u20137.","journal-title":"Haematologica"},{"issue":"5","key":"812_CR66","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/ng.3821","volume":"49","author":"DJ Wright","year":"2017","unstructured":"Wright DJ, Day FR, Kerrison ND, Zink F, Cardona A, Sulem P, et al. Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility. Nat genet. 2017;49(5):674\u20139.","journal-title":"Nat genet"},{"issue":"5","key":"812_CR67","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ng.3545","volume":"48","author":"W Zhou","year":"2016","unstructured":"Zhou W, Machiela MJ, Freedman ND, Rothman N, Malats N, Dagnall C, et al. Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nat Genet. 2016;48(5):563\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"812_CR68","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrg.2016.145","volume":"18","author":"LA Forsberg","year":"2017","unstructured":"Forsberg LA, Gisselsson D, Dumanski JP. Mosaicism in health and disease\u2014clones picking up speed. Nat Rev Genet. 2017;18(2):128\u201342.","journal-title":"Nat Rev Genet"},{"issue":"7784","key":"812_CR69","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","volume":"575","author":"DJ Thompson","year":"2019","unstructured":"Thompson DJ, Genovese G, Halvardson J, Ulirsch JC, Wright DJ, Terao C, et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature. 2019;575(7784):652\u20137.","journal-title":"Nature"},{"issue":"3","key":"812_CR70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00018-022-04160-1","volume":"79","author":"Y Ben-David","year":"2022","unstructured":"Ben-David Y, Gajendran B, Sample KM, Zacksenhaus E. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cell Mol Life Sci. 2022;79(3):163.","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"812_CR71","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/gcc.22282","volume":"54","author":"C Ganster","year":"2015","unstructured":"Ganster C, K\u00e4mpfe D, Jung K, Braulke F, Shirneshan K, Machherndl-Spandl S, et al. New data shed light on Y-loss-related pathogenesis in myelodysplastic syndromes. Genes Chromosom Cancer. 2015;54(12):717\u201324.","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"812_CR72","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41375-021-01456-2","volume":"36","author":"V Ljungstrom","year":"2022","unstructured":"Ljungstrom V, Mattisson J, Halvardson J, Pandzic T, Davies H, Rychlicka-Buniowska E, et al. Loss of Y and clonal hematopoiesis in blood-two sides of the same coin? Leukemia. 2022;36(3):889\u201391.","journal-title":"Leukemia"},{"key":"812_CR73","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.153768","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhao L, Yang Y, Li S, Liu Y, Chen C. Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis. JCI Insight. 2022. https:\/\/doi.org\/10.1172\/jci.insight.153768.","journal-title":"JCI Insight"},{"issue":"7","key":"812_CR74","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1158\/1541-7786.MCR-24-0105","volume":"22","author":"CD Dirican","year":"2024","unstructured":"Dirican CD, Nelson PS. Y chromosome loss and implications for oncology. Mol Cancer Res. 2024;22(7):603\u201312.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"812_CR75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cancergencyto.2005.08.022","volume":"166","author":"SJ Park","year":"2006","unstructured":"Park SJ, Jeong SY, Kim HJ. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Cancer Genet Cytogenet. 2006;166(1):56\u201364.","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"812_CR76","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/gcc.2870080306","volume":"8","author":"S Hunter","year":"1993","unstructured":"Hunter S, Gramlich T, Abbott K, Varma V. Y chromosome loss in esophageal carcinoma: an in situ hybridization study. Genes Chromosom Cancer. 1993;8(3):172\u20137.","journal-title":"Genes Chromosom Cancer"},{"issue":"22","key":"812_CR77","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.3390\/cancers16223766","volume":"16","author":"P Russo","year":"2024","unstructured":"Russo P, Bizzarri FP, Filomena GB, Marino F, Iacovelli R, Ciccarese C, et al. Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives. Cancers. 2024;16(22):3766.","journal-title":"Cancers"},{"issue":"14","key":"812_CR78","doi-asserted-by":"publisher","first-page":"P3125","DOI":"10.1016\/j.cell.2023.06.006","volume":"186","author":"M Qi","year":"2023","unstructured":"Qi M, Pang J, Mitsiades I, Lane AA, Rheinbay E. Loss of chromosome Y in primary tumors. Cell. 2023;186(14):P3125-36. E11.","journal-title":"Cell"},{"key":"812_CR79","unstructured":"Asafo-Agyei KO SH. Hepatocellular carcinoma StatPearlsUpdated 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559177\/."},{"issue":"3","key":"812_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10654-011-9647-5","volume":"27","author":"G Edgren","year":"2012","unstructured":"Edgren G, Liang L, Adami HO, Chang ET. Enigmatic sex disparities in cancer incidence. Eur j epidemiol. 2012;27(3):187\u201396.","journal-title":"Eur j epidemiol"},{"issue":"2","key":"812_CR81","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/1097-0142(19930715)72:2<369::AID-CNCR2820720210>3.0.CO;2-5","volume":"72","author":"K Tarao","year":"1993","unstructured":"Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, et al. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer. 1993;72(2):369\u201374.","journal-title":"Cancer"},{"issue":"1","key":"812_CR82","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","volume":"18","author":"A White","year":"2018","unstructured":"White A, Ironmonger L, Steele RJC, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer. 2018;18(1):906.","journal-title":"BMC Cancer"},{"issue":"4","key":"812_CR83","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/jwh.2011.2992","volume":"21","author":"PN Abotchie","year":"2012","unstructured":"Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 1975\u20132006. J Womens Health (Larchmt). 2012;21(4):393\u2013400.","journal-title":"J Womens Health (Larchmt)"},{"issue":"8","key":"812_CR84","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","volume":"20","author":"MB Cook","year":"2011","unstructured":"Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomark Prev. 2011;20(8):1629\u201337.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"812_CR85","first-page":"391","volume":"30","author":"D Tang","year":"2023","unstructured":"Tang D, Kang R. Glimmers of hope for targeting oncogenic KRAS-G12D. Cancer Gene Ther. 2023;30(3):391\u20133.","journal-title":"Cancer Gene Ther"},{"issue":"7970","key":"812_CR86","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41586-023-06254-7","volume":"619","author":"J Li","year":"2023","unstructured":"Li J, Lan Z, Liao W, Horner JW, Xu X, Liu J, et al. Histone demethylase KDM5D upregulation drives sex differences in colon cancer. Nature. 2023;619(7970):632\u20139.","journal-title":"Nature"},{"issue":"1","key":"812_CR87","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1038\/s41598-024-60049-y","volume":"14","author":"M W\u00f3jcik","year":"2024","unstructured":"W\u00f3jcik M, Juhas U, Mohammadi E, Mattisson J, Dr\u0119\u017cek-Chy\u0142a K, Rychlicka-Buniowska E, et al. Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases. Sci Rep. 2024;14(1):9458.","journal-title":"Sci Rep"},{"issue":"5","key":"812_CR88","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00439-017-1799-2","volume":"136","author":"F La","year":"2017","unstructured":"La F. Loss of chromosome Y (LOY) in blood cells is associated with increased risk for disease and mortality in aging men. Hum Genet. 2017;136(5):657\u201363.","journal-title":"Hum Genet"},{"issue":"26","key":"812_CR89","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","volume":"21","author":"MJ Arnal","year":"2015","unstructured":"Arnal MJ, Arenas \u00c1F, Arbeloa \u00c1L. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933\u201343.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"812_CR90","doi-asserted-by":"publisher","first-page":"e00281","DOI":"10.14309\/ctg.0000000000000281","volume":"12","author":"N Weygant","year":"2021","unstructured":"Weygant N, Chang K, Jackson CS, Vega KJ. Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival. Clin transl gastroenterol. 2021;12(1):e00281.","journal-title":"Clin transl gastroenterol"},{"key":"812_CR91","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/gcc.2870080306","volume":"8","author":"TG Stephen Hunter","year":"1993","unstructured":"Stephen Hunter TG, Abbott K, Varma V. Y chromosome loss in esophageal carcinoma: an in situ hybridization study. Genes Chromosom Cancer. 1993;8:172\u20137.","journal-title":"Genes Chromosom Cancer"},{"issue":"5","key":"812_CR92","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0091-7435(89)90046-7","volume":"18","author":"HS Garewal","year":"1989","unstructured":"Garewal HS, Sampliner R. Barrett\u2019s esophagus: a model premalignant lesion for adenocarcinoma. Prev Med. 1989;18(5):749\u201356.","journal-title":"Prev Med"},{"issue":"2","key":"812_CR93","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0165-4608(89)90096-4","volume":"42","author":"HS Garewal","year":"1989","unstructured":"Garewal HS, Sampliner R, Liu Y, Trent JM. Chromosomal rearrangements in Barrett\u2019s esophagus: a premalignant lesion of esophageal adenocarcinoma. Cancer Genet Cytogenet. 1989;42(2):281\u20136.","journal-title":"Cancer Genet Cytogenet"},{"issue":"9","key":"812_CR94","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69(9):1564\u201371.","journal-title":"Gut"},{"issue":"2","key":"812_CR95","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360\u201373.","journal-title":"Gastroenterology"},{"issue":"2A","key":"812_CR96","first-page":"985","volume":"21","author":"H Yamaki","year":"2001","unstructured":"Yamaki H, Sasano H, Ohashi Y, Shizawa S, Shineha R, Satomi S, et al. Alteration of X and Y chromosomes in human esophageal squamous cell carcinoma. Anticancer Res. 2001;21(2A):985\u201390.","journal-title":"Anticancer Res"},{"issue":"50","key":"812_CR97","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1038\/s41388-024-03193-z","volume":"43","author":"TW GongSun","year":"2024","unstructured":"GongSun TW, Li X, Cai J, Zhao N, Lu M, Xu J, et al. TMSB4Y restrains sphingomyelin synthesis via de novo purine synthesis to exert a tumor suppressor function in male esophageal squamous cell carcinoma. Oncogene. 2024;43(50):3660\u201372.","journal-title":"Oncogene"},{"issue":"42","key":"812_CR98","doi-asserted-by":"publisher","first-page":"44927","DOI":"10.18632\/oncotarget.6743","volume":"6","author":"HY Wong","year":"2015","unstructured":"Wong HY, Wang G, Croessmann S, Zabransky DJ, Chu D, Garay JP, et al. TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer. Oncotarget. 2015;6(42):44927\u201340.","journal-title":"Oncotarget"},{"issue":"1","key":"812_CR99","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto A, Jemal A. Cancer statistics. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"812_CR100","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3816\/CGC.2004.n.016","volume":"3","author":"Y Kinoshita","year":"2004","unstructured":"Kinoshita Y, Singh A, Rovito PM Jr, Wang CY, Haas GP. Double primary cancers of the prostate and bladder: a literature review. Clin Prostate Cancer. 2004;3(2):83\u20136.","journal-title":"Clin Prostate Cancer"},{"issue":"6","key":"812_CR101","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1086\/498455","volume":"77","author":"KL Nathanson","year":"2005","unstructured":"Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, et al. The Y deletion gr\/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet. 2005;77(6):1034\u201343.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"812_CR102","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jhg.2017.20","volume":"62","author":"MJ Machiela","year":"2017","unstructured":"Machiela MJ, Dagnall CL, Pathak A, Loud JT, Chanock SJ, Greene MH, et al. Mosaic chromosome Y loss and testicular germ cell tumor risk. J Hum Genet. 2017;62(6):637\u201340.","journal-title":"J Hum Genet"},{"issue":"12","key":"812_CR103","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.3390\/cancers15123108","volume":"15","author":"N Kl\u00fcmper","year":"2023","unstructured":"Kl\u00fcmper N, Ellinger J. Insights into urologic cancer. Cancers (Basel). 2023;15(12):3108.","journal-title":"Cancers (Basel)"},{"issue":"17","key":"812_CR104","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/jama.1947.62890170001007","volume":"135","author":"C Huggins","year":"1947","unstructured":"Huggins C, Johnson MA. Cancer of the bladder and prostate. JAMA. 1947;135(17):1146\u201352.","journal-title":"JAMA"},{"issue":"4","key":"812_CR105","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/00313021003767298","volume":"42","author":"S Minner","year":"2010","unstructured":"Minner S, Kilgu\u00e9 A, Stahl P, Weikert S, Rink M, Dahlem R, et al. Y chromosome loss is a frequent early event in urothelial bladder cancer. Pathology. 2010;42(4):356\u20139.","journal-title":"Pathology"},{"issue":"7970","key":"812_CR106","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-023-06234-x","volume":"619","author":"HA Abdel-Hafiz","year":"2023","unstructured":"Abdel-Hafiz HA, Schafer JM, Chen X, Xiao T, Gauntner TD, Li Z, et al. Y chromosome loss in cancer drives growth by evasion of adaptive immunity. Nature. 2023;619(7970):624\u201331.","journal-title":"Nature"},{"key":"812_CR107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0165-4608(90)90242-3","volume":"50","author":"MT Isaac Powell","year":"1990","unstructured":"Isaac Powell MT, Kleer E. Apparent correlation of sex chromosome loss and disease course in urothelial cancer. Cancer Genet Cytogenet. 1990;50:97\u2013101.","journal-title":"Cancer Genet Cytogenet"},{"issue":"4","key":"812_CR108","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/pros.23739","volume":"79","author":"VN Giri","year":"2019","unstructured":"Giri VN, Hegarty S, Hyatt C, O\u2019Leary E, Garcia J, Knudsen KE, et al. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing. Prostate. 2019;79(4):333\u20139.","journal-title":"Prostate"},{"issue":"2","key":"812_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-4608(93)90244-G","volume":"66","author":"H Van Dekken","year":"1993","unstructured":"Van Dekken H, Alers J. Loss of chromosome Y in prostatic cancer cells, but not in stromal tissue. Cancer Genet Cytogenet. 1993;66(2):131\u20132.","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"812_CR110","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0046-8177(96)90404-9","volume":"27","author":"JJ Konig","year":"1996","unstructured":"Konig JJ, Teubel W, Romijn JC, Schroder FH, Hagemeijer A. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. Hum pathol. 1996;27(7):720\u20137.","journal-title":"Hum pathol"},{"issue":"4","key":"812_CR111","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/gcc.20250","volume":"44","author":"S Vijayakumar","year":"2005","unstructured":"Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, Xiang R, et al. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice. Genes Chromosom Cancer. 2005;44(4):365\u201372.","journal-title":"Genes Chromosom Cancer"},{"issue":"22","key":"812_CR112","doi-asserted-by":"publisher","first-page":"6259","DOI":"10.1073\/pnas.1600420113","volume":"113","author":"K Komura","year":"2016","unstructured":"Komura K, Jeong SH, Hinohara K, Qu F, Wang X, Hiraki M, et al. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Proc Nat Acad Sci. 2016;113(22):6259\u201364.","journal-title":"Proc Nat Acad Sci."},{"issue":"3","key":"812_CR113","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2741\/e830","volume":"10","author":"R Patel","year":"2018","unstructured":"Patel R, Khalifa A, Isali I, Shukla S. Prostate cancer susceptibility and growth linked to Y chromosome genes. Front Biosci (Elite Ed). 2018;10(3):423\u201336.","journal-title":"Front Biosci (Elite Ed)"},{"issue":"3","key":"812_CR114","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21037\/atm-20-3061","volume":"9","author":"F B\u00fcscheck","year":"2021","unstructured":"B\u00fcscheck F, Fraune C, Garmestani S, Simon R, Kluth M, Hube-Magg C, et al. Y-chromosome loss is frequent in male renal tumors. Ann Transl Med. 2021;9(3):209.","journal-title":"Ann Transl Med."},{"issue":"10","key":"812_CR115","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/01.MP.0000090924.90762.94","volume":"16","author":"M Brunelli","year":"2003","unstructured":"Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod pathol. 2003;16(10):1053\u20139.","journal-title":"Mod pathol"},{"issue":"1","key":"812_CR116","doi-asserted-by":"publisher","first-page":"44876","DOI":"10.1038\/srep44876","volume":"7","author":"M Arseneault","year":"2017","unstructured":"Arseneault M, Monlong J, Vasudev NS, Laskar RS, Safisamghabadi M, Harnden P, et al. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. Sci Rep. 2017;7(1):44876.","journal-title":"Sci Rep"},{"key":"812_CR117","volume-title":"TNM classification","author":"RDRA Sapra","year":"2023","unstructured":"Sapra RDRA. TNM classification. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"812_CR118","volume-title":"Holland-Frei cancer medicine","author":"A Weston","year":"2003","unstructured":"Weston A, Harris CC, et al. Multistage carcinogenesis. In: Kufe DWPR, Weichselbaum RR, et al., editors. Holland-Frei cancer medicine. 6th ed. BC Decker: Hamilton (ON); 2003.","edition":"6"},{"issue":"1","key":"812_CR119","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12944-021-01581-y","volume":"20","author":"H Tallima","year":"2021","unstructured":"Tallima H, Azzazy HM, El Ridi R. Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion. Lipids health dis. 2021;20(1):150.","journal-title":"Lipids health dis"},{"issue":"1","key":"812_CR120","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct And Target Ther. 2024;9(1):149.","journal-title":"Signal Transduct And Target Ther."},{"issue":"3","key":"812_CR121","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41574-022-00773-5","volume":"19","author":"JS Brunner","year":"2023","unstructured":"Brunner JS, Finley LW. Metabolic determinants of tumour initiation. Rev Endocrinol. 2023;19(3):134\u201350.","journal-title":"Rev Endocrinol"},{"key":"812_CR122","volume-title":"The development and causes of cancer","author":"G Cooper","year":"2000","unstructured":"Cooper G. The development and causes of cancer. 2nd ed. Sunderland (MA): Sinauer Associates; 2000.","edition":"2"},{"issue":"2","key":"812_CR123","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"812_CR124","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.7150\/ijbs.72534","volume":"18","author":"A Zhang","year":"2022","unstructured":"Zhang A, Miao K, Sun H, Deng CX. Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int J Biol Sci. 2022;18(7):3019.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"812_CR125","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/cancers12071743","volume":"12","author":"H Loeser","year":"2020","unstructured":"Loeser H, W\u00f6lwer CB, Alakus H, Chon SH, Zander T, Buettner R, et al. Y chromosome loss is a frequent event in Barrett\u2019s adenocarcinoma and associated with poor outcome. Cancers. 2020;12(7):1743.","journal-title":"Cancers"},{"issue":"4","key":"812_CR126","doi-asserted-by":"publisher","first-page":"e0301989","DOI":"10.1371\/journal.pone.0301989","volume":"19","author":"SH Rajanala","year":"2024","unstructured":"Rajanala SH, Ghale R, Nandakumar S, Chadalavada K, Lee GS, Stopsack KH, et al. Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting. PLoS ONE. 2024;19(4):e0301989.","journal-title":"PLoS ONE"},{"issue":"2","key":"812_CR127","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/genes1020283","volume":"1","author":"T Kido","year":"2010","unstructured":"Kido T, Hatakeyama S, Ohyama C, Lau YF. Expression of the Y-Encoded TSPY is Associated with Progression of Prostate Cancer. Genes. 2010;1(2):283.","journal-title":"Genes"},{"issue":"1","key":"812_CR128","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2407-6-154","volume":"6","author":"SW Oram","year":"2006","unstructured":"Oram SW, Liu XX, Lee TL, Chan WY, Lau YF. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer. 2006;6(1):154. https:\/\/doi.org\/10.1186\/1471-2407-6-154.","journal-title":"BMC Cancer"},{"issue":"1\u20134","key":"812_CR129","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000056838","volume":"91","author":"Y Lau","year":"2000","unstructured":"Lau Y, Chou P, Iezzoni J, Alonzo J, K\u00f6m\u00fcves L. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet. 2000;91(1\u20134):160\u20134.","journal-title":"Cytogenet Cell Genet"},{"key":"812_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0287-x","author":"T Kido","year":"2019","unstructured":"Kido T, Lau Y. The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression. Cell Biosci. 2019. https:\/\/doi.org\/10.1186\/s13578-019-0287-x.","journal-title":"Cell Biosci"},{"issue":"5","key":"812_CR131","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/hmg\/ddx005","volume":"26","author":"Y Li","year":"2017","unstructured":"Li Y, Zhang DJ, Qiu Y, Kido T, Lau YF. The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants. Hum Mol Genet. 2017;26(5):901\u201312.","journal-title":"Hum Mol Genet"},{"key":"812_CR132","first-page":"39","volume-title":"Current problems in the epidemiology of cancer and lymphomas. Recent results in cancer research","author":"I Liav\u00e5g","year":"1972","unstructured":"Liav\u00e5g I, Harbitz TB, Haugen OA. Latent carcinoma of the prostate. In: GrundmannTulinius EH, editor. Current problems in the epidemiology of cancer and lymphomas. Recent results in cancer research. Berlin, Heidelberg: Springer; 1972. p. 39."},{"issue":"1","key":"812_CR133","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-3701-4-9","volume":"4","author":"T Kido","year":"2014","unstructured":"Kido T, Schubert S, Hatakeyama S, Ohyama C, Schmidtke J, Lau YF. Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer. Cell Biosci. 2014;4(1):9.","journal-title":"Cell Biosci"},{"issue":"11","key":"812_CR134","doi-asserted-by":"publisher","first-page":"779918","DOI":"10.3389\/fonc.2021.779918","volume":"7","author":"C Hua","year":"2021","unstructured":"Hua C, Chen J, Li S, Zhou J, Fu J, Sun W, et al. KDM6 demethylases and their roles in human cancers. Front Oncol. 2021;7(11):779918.","journal-title":"Front Oncol"},{"key":"812_CR135","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0448","author":"L Li","year":"2024","unstructured":"Li L, Zhu G, Gong C, Hu M, Tan K, Jiang L, et al. Histone demethylase KDM5D represses the proliferation, migration and invasion of hepatocellular carcinoma through the E2F1\/TNNC1 axis. Antioxid Redox Signal. 2024. https:\/\/doi.org\/10.1089\/ars.2023.0448.","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"812_CR136","doi-asserted-by":"publisher","first-page":"12247","DOI":"10.1002\/jcb.27308","volume":"120","author":"KH Xudong Shen","year":"2019","unstructured":"Xudong Shen KH, Cheng G, Xu L, Chen Z, Du P, Zhuang Z. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male. J Cell Biochem. 2019;120(8):12247\u201358.","journal-title":"J Cell Biochem"},{"issue":"3","key":"812_CR137","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2018.02.003","volume":"33","author":"J Andricovich","year":"2018","unstructured":"Andricovich J, Perkail S, Kai Y, Casasanta N, Peng W, Tzatsos A. Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors. Cancer Cell. 2018;33(3):512\u201326.","journal-title":"Cancer Cell"},{"issue":"6293","key":"812_CR138","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.aad9512","volume":"352","author":"A Dutta","year":"2016","unstructured":"Dutta A, Le Magnen C, Mitrofanova A, Ouyang X, Califano A, Abate-Shen C. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation. Science. 2016;352(6293):1576\u201380.","journal-title":"Science"},{"issue":"1","key":"812_CR139","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15(1):129.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"812_CR140","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE De Visser","year":"2023","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"812_CR141","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm.2328","volume":"17","author":"B Mj","year":"2011","unstructured":"Mj B. Why don\u2019t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011;17:320\u20139.","journal-title":"Nat Med"},{"issue":"4","key":"812_CR142","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-023-00660-9","volume":"24","author":"S Yuan","year":"2024","unstructured":"Yuan S, Almagro J, Fuchs E. Beyond genetics: driving cancer with the tumour microenvironment behind the wheel. Nat Rev Cancer. 2024;24(4):274\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"812_CR143","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/biom14040438","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma H, Gao Y, Liang Y, Du Y, Hao S, et al. The Tumor Microenvironment: Signal Transduction. Biomolecules. 2024;14(4):438.","journal-title":"Biomolecules"},{"issue":"16","key":"812_CR144","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30(16):R921\u20135.","journal-title":"Curr Biol"},{"issue":"10","key":"812_CR145","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC, Mu J, et al. Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med. 2023;12(10):11149\u201365.","journal-title":"Cancer Med"},{"issue":"6230","key":"812_CR146","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74\u201380.","journal-title":"Science"},{"issue":"45","key":"812_CR147","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904\u201312.","journal-title":"Oncogene"},{"issue":"51","key":"812_CR148","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1038\/sj.onc.1210535","volume":"26","author":"TK Ito","year":"2007","unstructured":"Ito TK, Ishii G, Chiba H, Ochiai A. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene. 2007;26(51):7194\u2013203.","journal-title":"Oncogene"},{"issue":"5","key":"812_CR149","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/carcin\/bgi351","volume":"27","author":"WS Wang","year":"2006","unstructured":"Wang WS, Chen PM, Wang HS, Liang WY, Su Y. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis. 2006;27(5):1113\u201320.","journal-title":"Carcinogenesis"},{"key":"812_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00033","author":"R Bhome","year":"2015","unstructured":"Bhome R, Bullock MD, Al Saihati HA, Goh RW, Primrose JN, Sayan AE, et al. A top-down view of the tumor microenvironment: structure, cells and signaling. Front Cell Dev Biol. 2015. https:\/\/doi.org\/10.3389\/fcell.2015.00033.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"812_CR151","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/cancers14071681","volume":"14","author":"AC Pe\u00f1a-Romero","year":"2022","unstructured":"Pe\u00f1a-Romero AC, Orenes-Pi\u00f1ero E. Dual effect of immune cells within tumour microenvironment: pro- and anti-tumour effects and their triggers. Cancers (Basel). 2022;14(7):1681.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"812_CR152","doi-asserted-by":"publisher","first-page":"e31877","DOI":"10.1016\/j.heliyon.2024.e31877","volume":"10","author":"Y Li","year":"2024","unstructured":"Li Y, Pan X, Luo W, Gamalla Y, Ma Z, Zhou P, et al. TMErisk score: a tumor microenvironment-based model for predicting prognosis and immunotherapy in patients with head and neck squamous cell carcinoma. Heliyon. 2024;10(11):e31877.","journal-title":"Heliyon"},{"issue":"1","key":"812_CR153","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12967-024-05990-2","volume":"22","author":"Z Feng","year":"2024","unstructured":"Feng Z, Liao M, Zhang L. Sex differences in disease: sex chromosome and immunity. J Transl Med. 2024;22(1):1150.","journal-title":"J Transl Med"},{"issue":"8","key":"812_CR154","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00018-021-03822-w","volume":"78","author":"JPJH DumanskiHalvardsonDavies","year":"2021","unstructured":"DumanskiHalvardsonDavies JPJH, Rychlicka-Buniowska E, Mattisson J, Moghadam BT, Nagy N, W\u0119glarczyk K, et al. Immune cells lacking Y chromosome show dysregulation of autosomal gene expression. Cell Mol Life Sci. 2021;78(8):4019\u201333.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"812_CR155","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s12307-012-0127-6","volume":"6","author":"SMSP HadrupDoniaThor","year":"2013","unstructured":"HadrupDoniaThor SMSP. Effector CD4 and CD8 T cells and their role in the tumor microenvironment. Cancer Microenviron. 2013;6(2):123\u201333.","journal-title":"Cancer Microenviron"},{"key":"812_CR156","first-page":"925135","volume":"2012","author":"RV Lukheeram","year":"2012","unstructured":"Lukheeram RV, Zour R, Verma AD, Xia B. CD4\u207aT cells: differentiation and functions. Clin Dev Immunol. 2012;2012:925135.","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"812_CR157","doi-asserted-by":"publisher","first-page":"e153768","DOI":"10.1172\/jci.insight.153768","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Zhao L, Yang Y, Li S, Liu Y, Chen C. Mosaic loss of chromosome Y promotes leukemogenesis and clonal hematopoiesis. JCI Insight. 2022;7(3):e153768.","journal-title":"JCI Insight"},{"issue":"1","key":"812_CR158","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1038\/s41598-021-94588-5","volume":"11","author":"JDM Mattisson","year":"2021","unstructured":"Mattisson JDM, Hammond M, Davies H, Gallant CJ, Nordlund J, Raine A, et al. Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99. Sci Rep. 2021;11(1):15160.","journal-title":"Sci Rep"},{"issue":"4","key":"812_CR159","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1172\/JCI22685","volume":"114","author":"ANG-PJ Houghton","year":"2004","unstructured":"Houghton ANG-PJ. Immune recognition of self in immunity against cancer. J Clin Invest. 2004;114(4):468\u201371.","journal-title":"J Clin Invest"},{"key":"812_CR160","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2016.ed61","volume":"10","author":"J Brierley","year":"2016","unstructured":"Brierley J, Gospodarowicz M, O\u2019Sullivan B. The principles of cancer staging. Ecancermedicalscience. 2016;10:ed61.","journal-title":"Ecancermedicalscience"},{"key":"812_CR161","volume-title":"Tumor staging and grading: a primer","author":"M Stacy","year":"2017","unstructured":"Stacy M, Telloni MD. Tumor staging and grading: a primer. New York: Humana Press; 2017."},{"issue":"11","key":"812_CR162","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DFJJ Quail","year":"2013","unstructured":"Quail DFJJ. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"1","key":"812_CR163","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"812_CR164","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s43018-024-00839-5","volume":"5","author":"KKNN Youssef","year":"2024","unstructured":"Youssef KKNN, Arcas A, Marquez-Galera A, Jim\u00e9nez-Casta\u00f1o R, Lopez-Blau C, Fazilaty H, et al. Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations. Nat Cancer. 2024;5(11):1660\u201380.","journal-title":"Nat Cancer"},{"issue":"10","key":"812_CR165","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1038\/cddis.2016.316","volume":"7","author":"RY Huang","year":"2016","unstructured":"Huang RY, Huang TY. A new dimension in drug discovery: reversing epithelial-mesenchymal transition (EMT). Cell Death Dis. 2016;7(10):e2417.","journal-title":"Cell Death Dis"},{"issue":"2","key":"812_CR166","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","volume":"101","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101(2):293\u20139.","journal-title":"Cancer Sci"},{"key":"812_CR167","doi-asserted-by":"publisher","first-page":"114814","DOI":"10.1016\/j.bcp.2021.114814","volume":"194","author":"M Liu","year":"2021","unstructured":"Liu M, Gao N. KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males. Biochem Pharmacol. 2021;194:114814.","journal-title":"Biochem Pharmacol"},{"issue":"50","key":"812_CR168","doi-asserted-by":"publisher","first-page":"e2402022121","DOI":"10.1073\/pnas.2402022121","volume":"121","author":"J Chen","year":"2024","unstructured":"Chen J, Wang T, Zhang D, Wang H, Huang Z, Yang Z, et al. KDM5D histone demethylase mediates p38\u03b1 inactivation via its enzymatic activity to inhibit cancer progression. Proc Natl Acad Sci U S A. 2024;121(50):e2402022121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"812_CR169","first-page":"6021602","volume":"2020","author":"W Meng","year":"2020","unstructured":"Meng W, Meng J, Jiang H, Feng X, Wei D, Ding Q. FKBP4 accelerates malignant progression of non-small-cell lung cancer by activating the Akt\/mTOR signaling pathway. Anal Cell Pathol (Amst). 2020;2020:6021602.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"4","key":"812_CR170","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/0008-5472.CAN-15-0906","volume":"76","author":"N Li","year":"2016","unstructured":"Li N, Dhar SS, Chen TY, Kan PY, Wei Y, Kim JH, et al. JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis. Cancer Res. 2016;76(4):831\u201343.","journal-title":"Cancer Res"},{"issue":"7","key":"812_CR171","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1172\/JCI96769","volume":"128","author":"K Komura","year":"2018","unstructured":"Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, et al. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D. J Clin Invest. 2018;128(7):2979\u201395.","journal-title":"J Clin Invest"},{"key":"812_CR172","doi-asserted-by":"publisher","first-page":"112571","DOI":"10.1016\/j.intimp.2024.112571","volume":"138","author":"Y Hu","year":"2024","unstructured":"Hu Y, Zhang Y, Shi F, Yang R, Yan J, Han T, et al. Reversal of T-cell exhaustion: mechanisms and synergistic approaches. Int Immunopharmacol. 2024;138:112571.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"812_CR173","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00281-022-00966-0","volume":"45","author":"MH Andersen","year":"2023","unstructured":"Andersen MH. Tumor microenvironment antigens. Semin Immunopathol. 2023;45(2):253\u201364.","journal-title":"Semin Immunopathol"},{"issue":"2\u20133","key":"812_CR174","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12026-014-8514-3","volume":"58","author":"R Popli","year":"2014","unstructured":"Popli R, Sahaf B, Nakasone H, Lee JY, Miklos DB. Clinical impact of H-Y alloimmunity. Immunol Res. 2014;58(2\u20133):249\u201358.","journal-title":"Immunol Res"},{"issue":"1","key":"812_CR175","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther. 2021;6(1):72.","journal-title":"Signal Transduct Target Ther"},{"key":"812_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6721","author":"YXJ Wang","year":"2023","unstructured":"Wang YXJ, Lan T, Zhou C, Liu P. The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity. Cancer Med. 2023. https:\/\/doi.org\/10.1002\/cam4.6721.","journal-title":"Cancer Med"},{"issue":"11","key":"812_CR177","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"CCT Galassi","year":"2024","unstructured":"Galassi CCT, Vitale I, Galluzzi L. The hallmarks of cancer immune evasion. Cancer Cell. 2024;42(11):1825\u201363.","journal-title":"Cancer Cell"},{"issue":"11","key":"812_CR178","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.4049\/jimmunol.173.11.7046","volume":"173","author":"HAY Torikai","year":"2004","unstructured":"Torikai HAY, Miyazaki M, Warren EH 3rd, Oba T, Tsujimura K, Motoyoshi K, et al. A novel HLA-A*3303-restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol. 2004;173(11):7046\u201354.","journal-title":"J Immunol"},{"issue":"1","key":"812_CR179","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1469-1809.1981.tb00305.x","volume":"45","author":"L Alvesalo","year":"1981","unstructured":"Alvesalo L, Chapelle AD. Tooth sizes in two males with deletions of the long arm of the Y-chromosome. Ann Hum Genet. 1981;45(1):49\u201354.","journal-title":"Ann Hum Genet"},{"issue":"2","key":"812_CR180","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0888-7543(91)90251-9","volume":"9","author":"Y Nakahori","year":"1991","unstructured":"Nakahori Y, Takenaka O, Nakagome Y. A human X-Y homologous region encodes \u201camelogenin.\u201d Genomics. 1991;9(2):264\u20139.","journal-title":"Genomics"},{"issue":"3","key":"812_CR181","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3892\/ol.2013.1122","volume":"5","author":"L Qi","year":"2013","unstructured":"Qi L, Wang L, Huang J, Jiang M, Diao H, Zhou H, et al. Activated amelogenin Y-linked (AMELY) regulation and angiogenesis in human hepatocellular carcinoma by biocomputation. Oncol Lett. 2013;5(3):1075\u20139.","journal-title":"Oncol Lett"},{"issue":"6","key":"812_CR182","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/0092-8674(90)90416-C","volume":"63","author":"B-RPEM Fisher","year":"1990","unstructured":"Fisher B-RPEM, Brown LG, Ridley A, McNeil JA, Lawrence JB, Willard HF, et al. Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell. 1990;63(6):1205\u201318.","journal-title":"Cell"},{"key":"812_CR183","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.2147\/DMSO.S329209","volume":"14","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chen Y, Tang C, Zhao Q, Xu T, Kang Q, et al. RPS4Y1 promotes high glucose-induced endothelial cell apoptosis and inflammation by activation of the p38 MAPK signaling. Diabetes Metab Syndr Obes. 2021;14:4523\u201334.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10","key":"812_CR184","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1097\/MS9.0000000000002535","volume":"86","author":"KP Giri","year":"2024","unstructured":"Giri KP, Thapa S, Rawat R, Rouniyar S. Unanticipated diagnosis of Swyer syndrome: a case report. Ann Med Surg (Lond). 2024;86(10):6293\u20139.","journal-title":"Ann Med Surg (Lond)"},{"issue":"4","key":"812_CR185","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/7.4.737","volume":"7","author":"A Greenfield","year":"1998","unstructured":"Greenfield A, Carrel L, Pennisi D, Philippe C, Quaderi N, Siggers P, et al. The UTX gene escapes X inactivation in mice and humans. Hum Mol Genet. 1998;7(4):737\u201342.","journal-title":"Hum Mol Genet"},{"issue":"39","key":"812_CR186","doi-asserted-by":"publisher","first-page":"63252","DOI":"10.18632\/oncotarget.11207","volume":"7","author":"J Ahn","year":"2016","unstructured":"Ahn J, Kim KH, Park S, Ahn YH, Kim HY, Yoon H, et al. Target sequencing and CRISPR\/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer. Oncotarget. 2016;7(39):63252\u201360.","journal-title":"Oncotarget"},{"issue":"1208","key":"812_CR187","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1098\/rstb.1988.0123","volume":"322","author":"DC Page","year":"1988","unstructured":"Page DC. Is ZFY the sex-determining gene on the human Y chromosome? April 1989. Philos Trans R Soc Lond B Biol Sci. 1988;322(1208):155\u20137.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"812_CR188","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaad025","author":"H Holmlund","year":"2023","unstructured":"Holmlund H, Yamauchi Y, Ruthig VA, Cocquet J, Ward MA. Return of the forgotten hero: the role of Y chromosome-encoded Zfy in male reproduction. Mol Hum Reprod. 2023. https:\/\/doi.org\/10.1093\/molehr\/gaad025.","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"812_CR189","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ng1096-128","volume":"14","author":"MGMM Kent-First","year":"1996","unstructured":"Kent-First MGMM, Muallem A, Brisco P, Shultz J, Ekenberg S, Agulnik AI, et al. Gene sequence and evolutionary conservation of human SMCY. Nat Genet. 1996;14(2):128\u20139.","journal-title":"Nat Genet"},{"issue":"11","key":"812_CR190","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/hmg\/5.11.1695","volume":"5","author":"MH Jones","year":"1996","unstructured":"Jones MH, Furlong RA, Burkin H, Chalmers IJ, Brown GM, Khwaja O, et al. The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. Hum Mol Genet. 1996;5(11):1695\u2013701.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"812_CR191","doi-asserted-by":"publisher","first-page":"152132","DOI":"10.1016\/j.acthis.2023.152132","volume":"126","author":"L Xiu","year":"2024","unstructured":"Xiu L, Ma B, Ding L. Antioncogenic roles of USP9Y and DDX3Y in lung cancer: USP9Y stabilizes DDX3Y by preventing its degradation through deubiquitination. Acta Histochem. 2024;126(1):152132.","journal-title":"Acta Histochem"},{"issue":"5338","key":"812_CR192","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.278.5338.675","volume":"278","author":"BT Lahn","year":"1997","unstructured":"Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science. 1997;278(5338):675\u201380.","journal-title":"Science"},{"issue":"1","key":"812_CR193","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/dnares\/6.1.63","volume":"6","author":"T Nagase","year":"1999","unstructured":"Nagase T, Kikuno I, Suyama M, Kikuno R, Hirosawa M, Miyajima N, et al. Prediction of the coding sequences of unidentified human genes XIII The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1999;6(1):63\u201370.","journal-title":"DNA Res"},{"issue":"42","key":"812_CR194","doi-asserted-by":"publisher","first-page":"68688","DOI":"10.18632\/oncotarget.11925","volume":"7","author":"Y Gong","year":"2016","unstructured":"Gong Y, Wang L, Chippada-Venkata U, Dai X, Oh WK, Zhu J. Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression. Oncotarget. 2016;7(42):68688\u2013707.","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"812_CR195","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000015510","volume":"88","author":"A Ratti","year":"2000","unstructured":"Ratti A, Stuppia L, Gatta V, Fogh I, Calabrese G, Pizzuti A, et al. Characterization of a new TSPY gene family member in Yq (TSPYq1). Cytogenet Cell Genet. 2000;88(1\u20132):159\u201362.","journal-title":"Cytogenet Cell Genet"},{"issue":"1","key":"812_CR196","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0888-7543(91)90107-P","volume":"11","author":"J Arnemann","year":"1991","unstructured":"Arnemann J, Jakubiczka S, Th\u00fcring S, Schmidtke J. Cloning and sequence analysis of a human Y-chromosome-derived, testicular cDNA, TSPY. Genomics. 1991;11(1):108\u201314.","journal-title":"Genomics"},{"issue":"51","key":"812_CR197","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1038\/sj.onc.1205991","volume":"21","author":"MW Chen","year":"2002","unstructured":"Chen MW, Vacherot F, De La Taille A, Gil-Diez-De-Medina S, Shen R, Friedman RA, et al. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells. Oncogene. 2002;21(51):7861\u201371.","journal-title":"Oncogene"},{"issue":"10","key":"812_CR198","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s003350010177","volume":"11","author":"P Blanco","year":"2000","unstructured":"Blanco P, Sargent CA, Boucher CA, Mitchell M, Affara NA. Conservation of PCDHX in mammals; expression of human X\/Y genes predominantly in brain. Mamm Genom. 2000;11(10):906\u201314.","journal-title":"Mamm Genom"},{"issue":"8","key":"812_CR199","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00335-002-3010-9","volume":"13","author":"P Blanco-Arias","year":"2002","unstructured":"Blanco-Arias P, Sargent CA, Affara NA. The human-specific Yp11.2\/Xq21.3 homology block encodes a potentially functional testis-specific TGIF-like retroposon. Mamm Genom. 2002;13(8):463\u20138.","journal-title":"Mamm Genom"},{"issue":"1","key":"812_CR200","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12032-008-9086-7","volume":"26","author":"ZAM Ousati Ashtiani","year":"2009","unstructured":"Ousati Ashtiani ZAM, Modarresi MH, Raoofian R, Sabah Goulian B, Greene WK, Heidari M. Association of TGIFLX\/Y mRNA expression with prostate cancer. Med Oncol. 2009;26(1):73\u20137.","journal-title":"Med Oncol"},{"issue":"6","key":"812_CR201","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1086\/302408","volume":"64","author":"MTRR Bassi","year":"1999","unstructured":"Bassi MTRR, Caciotti B, Winship IM, De Grandi A, Riboni M, Townes PL, et al. X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats. Am J Hum Genet. 1999;64(6):1604\u201316.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"812_CR202","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41431-018-0282-4","volume":"27","author":"M Di Stazio","year":"2019","unstructured":"Di Stazio M, Collesi C, Vozzi D, Liu W, Myers M, Morgan A, et al. TBL1Y: a new gene involved in syndromic hearing loss. Eur J Hum Genet. 2019;27(3):466\u201374.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"812_CR203","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10038-005-0237-9","volume":"50","author":"HT Yan","year":"2005","unstructured":"Yan HT, Shinka T, Kinoshita K, Sato Y, Umeno M, Chen G, et al. Molecular analysis of TBL1Y, a Y-linked homologue of TBL1X related with X-linked late-onset sensorineural deafness. J Hum Genet. 2005;50(4):175\u201381.","journal-title":"J Hum Genet"},{"key":"812_CR204","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-11-33","author":"AMMR Lopes","year":"2010","unstructured":"Lopes AMMR, Sargent CA, Ellis PJ, Amorim A, Affara NA. The human RPS4 paralogue on Yq11.223 encodes a structurally conserved ribosomal protein and is preferentially expressed during spermatogenesis. BMC Mol Biol. 2010. https:\/\/doi.org\/10.1186\/1471-2199-11-33.","journal-title":"BMC Mol Biol"},{"issue":"22","key":"812_CR205","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.3390\/cancers16223766","volume":"16","author":"P Russo","year":"2024","unstructured":"Russo P, Bizzarri FP, Filomena GB, Marino F, Iacovelli R, Ciccarese C, et al. Relationship between loss of Y chromosome and urologic cancers: new future perspectives. Cancers. 2024;16(22):3766.","journal-title":"Cancers"},{"issue":"1","key":"812_CR206","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-4608(98)00245-3","volume":"112","author":"WE de Graaff","year":"1999","unstructured":"de Graaff WE, van Echten J, van der Veen AY, Sleijfer DT, Timmer A, Koops HS, et al. Loss of the Y-chromosome in the primary metastasis of a male sex cord stromal tumor: pathogenetic implications. Cancer Genet Cytogenet. 1999;112(1):21\u20135.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"812_CR207","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2003.11.006","volume":"208","author":"MJM Kujawski","year":"2004","unstructured":"Kujawski MJM, Rydzanicz M, Szukala K, Wierzbicka M, Grenman R, Golusinski W, et al. Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region. Cancer Lett. 2004;208(1):95\u2013101.","journal-title":"Cancer Lett"},{"issue":"5","key":"812_CR208","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1200\/JCO.2007.15.8345","volume":"27","author":"T Klatte","year":"2009","unstructured":"Klatte T, Rao PN, de Martino M, LaRochelle J, Shuch B, Zomorodian N, et al. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol. 2009;27(5):746\u201353.","journal-title":"J Clin Oncol"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00812-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:11:29Z","timestamp":1762884689000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00812-9","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.K.T has served as a site-PI on pharma\/industry-sponsored clinical trials from Kite Pharma Inc., Lumicell, Inc., Dendron Pharmaceuticals, LLC, Oncovir Inc., Blue Earth Diagnostics Ltd., RhoVac ApS., Bayer HealthCare Pharmecauticals Inc., Janssen Research and Development, LLC. Dr. A.K.T has served as an unpaid consultant to Roivant Biosciences and advisor to Promaxo. He owns equity in Promaxo. G.C. has served as a scientific consultant for GuidePoint and received consultation fees. All the figures are generated using Biorender.com.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}